Study of Oral PQR309 in Patients With Advanced Solid Tumors

Condition:   Cancer
Intervention:   Drug: PQR 309
Sponsors:   PIQUR Therapeutics AG;   Roswell Park Cancer Institute;   M.D. Anderson Cancer Center;   University Hospitals Cleveland Medical Center;   Mayo Clinic;   Hospital Clinic of Barcelona;   University College London Hospitals;   Churchill Hospital
Recruiting - verified March 2017

http://ift.tt/2oqcVvN